News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Holles Natalie C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
4
| Holles Natalie C. (CEO) has filed a Form 4 on Third Harmonic Bio, Inc.|
Txns:
| Disposed/sold 467,634 options to buy
@ $9.22, valued at
$4.3M
Granted 467,634 options to buy
@ $4.2, valued at
$2M
Disposed/sold 205,000 options to buy
@ $18.4, valued at
$3.8M
Granted 205,000 options to buy
@ $4.2, valued at
$861k
Granted 360,000 options to buy
@ $4.2, valued at
$1.5M
|
|
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Holles Natalie C. (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Granted 28,700 options to buy
@ $16.29, valued at
$467.5k
|
|
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/14/2021 |
4
| Holles Natalie C. (Director) has filed a Form 4 on Allakos Inc.|
Txns:
| Granted 7,700 options to buy
@ $99.83, valued at
$768.7k
|
|
| 05/13/2021 |
4
| Holles Natalie C. (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $23.25, valued at
$581.3k
|
|
| 01/06/2021 |
4
| Holles Natalie C. (Director) has filed a Form 4 on Allakos Inc.|
Txns:
| Granted 4,000 options to buy
@ $133.77, valued at
$535.1k
|
|
| 05/26/2020 |
4
| Holles Natalie C. (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $6.22, valued at
$155.5k
|
|
| 01/15/2020 |
4
| Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Unknown transaction of 104,439 shares
@ $60, valued at
$6.3M
Disposed/sold 110,703 options to buy
@ $2.7649, valued at
$306.1k
Disposed/sold 548 options to buy
@ $9.4988, valued at
$5.2k
Disposed/sold 40,883 options to buy
@ $15.26, valued at
$623.9k
Disposed/sold 93,109 options to buy
@ $27.39, valued at
$2.6M
Disposed/sold 25,000 options to buy
@ $36.39, valued at
$909.8k
Disposed/sold 50,105 options to buy
@ $24.74, valued at
$1.2M
|
|
| 12/16/2019 |
4
| Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 8,681 shares
@ $59.37, valued at
$515.4k
Paid exercise price by delivering 88,928 shares
@ $59.37, valued at
$5.3M
Exercised 45,726 options to buy
@ $2.7649, valued at
$126.4k
Exercised 5,715 options to buy
@ $9.4988, valued at
$54.3k
Exercised 74,117 options to buy
@ $15.26, valued at
$1.1M
Exercised 6,891 options to buy
@ $27.39, valued at
$188.7k
Exercised 14,895 options to buy
@ $24.74, valued at
$368.5k
|
|
| 12/09/2019 |
4
| Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 505 shares
@ $59.21, valued at
$29.9k
|
|
| 09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,009 shares
@ $37.31, valued at
$37.6k
|
|
| 04/01/2019 |
4
| Holles Natalie C. (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $18.1, valued at
$905k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2019 |
4
| Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Exercised 8,300 options to buy
@ $2.7649, valued at
$22.9k
|
|
| 06/04/2018 |
4
| Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Exercised 5,090 options to buy
@ $2.7649, valued at
$14.1k
|
|
| 05/08/2018 |
4
| Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $36.39, valued at
$909.8k
|
|
| 11/17/2017 |
4
| Holles Natalie C. (Senior Vice President, COO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $27.39, valued at
$2.7M
|
|
| 06/01/2017 |
4
| Holles Natalie C. (Senior Vice President, COO) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Exercised 20,000 options to buy
@ $2.76, valued at
$55.2k
|
|
| 01/27/2017 |
4
| Holles Natalie C. (Senior Vice President, COO) has filed a Form 4 on Audentes Therapeutics, Inc. |
| 05/08/2015 |
4
| Holles Natalie C. (SVP, Business Development) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Unknown transaction of 702 shares
@ $46, valued at
$32.3k
Disposed/sold 17,750 shares
@ $46, valued at
$816.5k
Disposed/sold 63,000 options to buy
@ $22.02, valued at
$1.4M
Disposed/sold 21,000 options to buy
@ $22.06, valued at
$463.3k
Disposed/sold 29,000 options to buy
@ $26.74, valued at
$775.5k
Disposed/sold 24,000 options to buy
@ $25.97, valued at
$623.3k
|
|
| 02/10/2015 |
4
| Holles Natalie C. (SVP, Business Development) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Granted 14,000 shares
@ $0
Granted 24,000 options to buy
@ $25.97, valued at
$623.3k
|
|
| 01/05/2015 |
4
| Holles Natalie C. (SVP, Business Development) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 548 shares
@ $24.28, valued at
$13.3k
|
|
| 03/13/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/19/2013 |
4
| Holles Natalie C. (SVP, Corp & Business Dev) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Granted 21,000 options to buy
@ $22.06, valued at
$463.3k
|
|
| 07/02/2013 |
4
| Holles Natalie C. (SVP, Corp & Business Dev) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Granted 63,000 options to buy
@ $22.02, valued at
$1.4M
|
|
|
|